EternoGen Aesthetics LLC:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:EternoGen Aesthetics LLC - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10452
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
EternoGen Aesthetics LLC (EA) a subsidiary of EternoGen LLC, is a clinical stage medical device company which develops and manufactures advanced collagen scaffolds to deliver bio dermal restoration in facial aesthetics. Its portfolio of collagen products include rapid polymerizing collagen (RPC) solution with EDTA and D-Mannitol is injected through a fine gauge needle or micro-cannula forms fibrous scaffold in contact with dermal or subcutaneous tissue gets converted to contour stable matrix which inhibits degradation and infill the scaffold forming natural tissue to support and reinforce the wrinkled skin; CG NanoMatrix harnesses collagen degradation, stimulate tissue regeneration and reduce inflammation formulated to extend duration to around two years. The company markets and distributes its products non-surgical medical aesthetic market. EA is headquartered in Columbia, Missouri, the US.

EternoGen Aesthetics LLC – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EternoGen Aesthetics LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EternoGen Aesthetics LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
EternoGen Aesthetics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EternoGen Aesthetics LLC, Medical Equipment, Deal Details 10
Venture Financing 10
EternoGen Aesthetics to Raise Funds through Venture Financing 10
EternoGen Aesthetics Raises USD5 Million in Venture Financing 11
EternoGen Aesthetics Raises Additional USD0.7 Million in Venture Financing 12
EternoGen Aesthetics Raises USD0.1 Million in Venture Financing 13
Dermelle Raises US$1 Million In Venture Financing 14
EternoGen Aesthetics LLC – Key Competitors 15
EternoGen Aesthetics LLC – Key Employees 16
EternoGen Aesthetics LLC – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Jan 04, 2017: EternoGen opens offices at M2D2 18
Corporate Communications 19
Jan 04, 2017: EternoGen opens offices at M2D2 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
EternoGen Aesthetics LLC, Medical Equipment, Key Facts 2
EternoGen Aesthetics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EternoGen Aesthetics LLC, Medical Equipment Deals By Type, 2012 to YTD 2018 6
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EternoGen Aesthetics LLC, Deals By Market, 2012 to YTD 2018 8
EternoGen Aesthetics LLC, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
EternoGen Aesthetics to Raise Funds through Venture Financing 10
EternoGen Aesthetics Raises USD5 Million in Venture Financing 11
EternoGen Aesthetics Raises Additional USD0.7 Million in Venture Financing 12
EternoGen Aesthetics Raises USD0.1 Million in Venture Financing 13
Dermelle Raises US$1 Million In Venture Financing 14
EternoGen Aesthetics LLC, Key Competitors 15
EternoGen Aesthetics LLC, Key Employees 16
EternoGen Aesthetics LLC, Other Locations 17

List of Figures
EternoGen Aesthetics LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
EternoGen Aesthetics LLC, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
EternoGen Aesthetics LLC, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
EternoGen Aesthetics LLC, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
EternoGen Aesthetics LLC, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[EternoGen Aesthetics LLC:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lutron Electronics Co Inc:企業の戦略的SWOT分析
    Lutron Electronics Co Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Shinsung Solar Energy Co Ltd (011930)-エネルギー分野:企業M&A・提携分析
    Summary Shinsung Solar Energy Co., Ltd. (Shinsung Solar) is a provider of solar cells. Its products include single-crystalline and multi-crystalline solar cells, and mono-crystalline and multi-crystalline solar panels. Through its subsidiaries, the company offers installment financing, lease financi …
  • TransDigm Group Incorporated:企業の戦略・SWOT・財務情報
    TransDigm Group Incorporated - Strategy, SWOT and Corporate Finance Report Summary TransDigm Group Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Kumagai Gumi Co Ltd (1861):企業の財務・戦略的SWOT分析
    Kumagai Gumi Co Ltd (1861) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Medistim ASA (MEDI):企業の財務・戦略的SWOT分析
    Summary MediStim ASA (MediStim) is a medical device company that manufactures and markets medical products for cardiac, vascular and transplant surgeries. The company’s products include MiraQ cardiac, MiraQ vascular, MiraQ ultimate system, imaging probes, flow probes, VeriQ C and VeriQ systems. Its …
  • iRobot Corp (IRBT):企業の財務・戦略的SWOT分析
    iRobot Corp (IRBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Neurotez Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurotez Inc (Neurotez) is a biotechnology company that develops and markets leptin product, a novel hormone replacement therapy for Alzheimer’s disease (AD). The company's product pipeline includes leptin, NT1, NT2, and others. Its product leptin is an adipocyte hormone that controls energy …
  • Stockland Corporation Ltd:企業のM&A・事業提携・投資動向
    Stockland Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Stockland Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • WPP Plc (WPP):企業の財務・戦略的SWOT分析
    WPP Plc (WPP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Bionik Laboratories Corp (BNKL):企業の財務・戦略的SWOT分析
    Summary Bionik Laboratories Corp (Bionik) is a medical device company that designs and develops transformational technologies, prosthetics and assisted robotic products and solutions. The company offers rehabilitation technology that senses patient movements and limitations. It provides lower body e …
  • Adamis Pharmaceuticals Corp (ADMP)-医療機器分野:企業M&A・提携分析
    Summary Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc is a biopharmaceutical company that offers therapies. The company develops and commercializes products in the therapeutic areas of allergy and respiratory diseases. Its pipeline product, epinephrine pre-filled syringe …
  • Aesculap Inc:企業の製品パイプライン分析2018
    Summary Aesculap Inc (Aesculap) is a medical device company that offers medical implants, surgical implants, and other related devices. The company’s products comprise neurosurgery products, power systems, sterile processing products, surgical instruments, and wound closure products. It offers servi …
  • DiaMedica Therapeutics Inc (DMA):企業の財務・戦略的SWOT分析
    Summary DiaMedica Therapeutics Inc (DiaMedica) formerly DiaMedica Inc, is a clinical-stage bio pharmaceutical company which develops innovative medicines for the treatment neurological and kidney diseases. Its lead product candidate DM-199, is a human recombinant protein that treats diabetes type 1 …
  • University of Texas Health Science Center at San Antonio-製薬・医療分野:企業M&A・提携分析
    Summary University of Texas Health Science Center at San Antonio (UTHSCSA), a subsidiary of University of Texas System is an educational university that offers undergraduate, graduate, and research programs to physicians, biomedical scientists, aging and longevity, cancer, cardiovascular, diabetes, …
  • CJ ENM Co., Ltd. (035760):企業の財務・戦略的SWOT分析
    CJ ENM Co., Ltd. (035760) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Pinnacle West Capital Corporation (PNW):企業の財務・戦略的SWOT分析
    Pinnacle West Capital Corporation (PNW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Briggs & Stratton Corp (BGG):企業の財務・戦略的SWOT分析
    Briggs & Stratton Corp (BGG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Eniro AB (ENRO):企業の財務・戦略的SWOT分析
    Eniro AB (ENRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Eden Innovations (EDE):石油・ガス:M&Aディール及び事業提携情報
    Summary Eden Innovations, formerly Eden Energy Ltd, is a clean energy company that offers carbon nanotube and carbon fibre production, nanomaterial concrete admixtures, hydrogen production, and storage and transport fuel system. The company manufactures and distributes fuel systems, pumps, fuel tank …
  • Flatiron Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Flatiron Health Inc (Flatiron Health) a subsidiary of F. Hoffmann-La Roche Ltd, is a healthcare technology company which develops a learning healthcare system in oncology. The company offers a web-based business and clinical intelligence data platform that integrates and structures disparate …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆